ESC Premium Access

The genetic background of the disease in a group of patients with severe course of hypertrophic cardiomyopathy.

Congress Presentation

About the speaker

Doctor Mariusz Klopotowski

Institute of Cardiology, Warsaw (Poland)
0 follower

11 more presentations in this session

Glutamine-fructose-6-phosphate amidotransferase 2 mediates isoproterenol-induced cardiac hypertrophy by increasing Akt O-GlcNAcylation through hexosamine biosynthesis pathway

Speaker: Doctor A. Ishikita (Fukuoka, JP)


Epigenetic modifications via histone acetylation by p300 are changed during the transition from cardiac hypertrophy to heart failure

Speaker: Mr Y. Sunagawa (Shizuoka, JP)


Inhibition of GATA4 dimerization suppress hypertrophic responses

Speaker: Mr S. Shimizu (Shizuoka, JP)


Adverse left ventricular remodeling in descending thoracic vs ascending aorta banding in novel porcin model. cMRI study

Speaker: Doctor S. Popevska (Leuven, BE)


Non-invasive predictors of LV biopsy-obtained creatine kinase activity in patients with non-failing and failing myocardial hypertrophy

Speaker: Doctor M. Peterzan (London, GB)


Access the full session

Poster Session 2 - Cardiac hypertrophy

Speakers: Doctor M. Klopotowski, Doctor A. Ishikita, Mr Y. Sunagawa, Mr S. Shimizu, Doctor S. Popevska...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb